title: Recombinant factor VIIa to successfully manage disseminated intravascular coagulation from amniotic fluid embolism.
abstract: BACKGROUND
  Amniotic fluid embolism (AFE) is a rare syndrome that can complicate pregnancy and labor. It often has debilitating and lethal consequences. One serious sequela of AFE is disseminated intravascular coagulation (DIC).
  
  
  METHODS
  This report describes an atypical presentation of AFE manifested by sudden fetal bradycardia and complicated by maternal DIC. The DIC was eventually successfully treated with the use of recombinant activated factor VIIa.
  
  
  CONCLUSIONS
  The use of recombinant activated factor VIIa in cases of massive hemorrhage, such as in our patient, is controversial but has been shown, in some cases, to reverse DIC and be successful. The use of recombinant activated factor VIIa should be considered in patients with massive obstetric hemorrhage in whom standard measures of stabilization are unsuccessful.
authors.affiliation: Department of Maternal Fetal Medicine, Hennepin County Medical Center, Minneapolis, Minnesota 55415, USA.
authors.forename: Soumathy C
authors.initials: SC
authors.lastname: Prosper
authors.forename: Christine S
authors.initials: CS
authors.lastname: Goudge
authors.forename: Virginia R
authors.initials: VR
authors.lastname: Lupo
mesh_terms: D000328:Adult; D002585:Cesarean Section; D003937:Diagnosis, Differential; D004211:Disseminated Intravascular Coagulation / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology; D004619:Embolism, Amniotic Fluid; D015942:Factor VIIa / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D011247:Pregnancy; D011263:Pregnancy Trimester, Third; D011296:Prenatal Diagnosis
chemical_list: D015942:Factor VIIa